Novitium Pharma - Ownership and Business Overview

Life ScienceCompany

Novitium Pharma Ownership

Who owns Novitium Pharma?

Novitium Pharma is owned by ANI Pharmaceuticals. It was acquired on March 9, 2021.

Novitium Pharma Business Overview

Where is Novitium Pharma headquartered?

Novitium Pharma is headquartered in East Windsor, New Jersey.

What sector is Novitium Pharma in?

Novitium Pharma is a life science company.

When was Novitium Pharma founded?

Novitium Pharma was founded in 2016.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 388 acquisitions of life science companies in 2021, including 44 acquisitions by private equity firms, and 344 by strategics.

Novitium Pharma

70 Lake Drive,
East Windsor, New Jersey 08520
United States,
(855) 204-1431
www.novitiumpharma.com

With operations in East Windsor, New Jersey, and Chennai, India, Novitium Pharma is a U.S.-based pharmaceutical company that specializes in the development, manufacturing, and distribution of niche generic products. The Company, founded in 2016, by Samy Shanmugam, Chad Gassert, and Vijay Thorappadi, has since developed a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories.


 Subscribe to unlock this and 202,005
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.